The Hindu·2 min read·medium
Aurobindo arm CuraTeQ Biologics’ facility secures nod from Brazil’s health regulator
T
The Hindu Bureau
✦AI Summary
Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has received approval from Brazil's health regulator, Anvisa, for its biosimilars manufacturing facility in Hyderabad. This certification allows the company to expand its reach into the Latin American market.
Aurobindo Pharma subsidiary CuraTeQ Biologics’ biosimilars manufacturing facility in Hyderabad has received Brazilian health regulator Anvisa’s approval, enabling it to tap the broader Latin American market..
businesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in